{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T21:52:37Z","timestamp":1771019557725,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-022-08927-z","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T06:02:31Z","timestamp":1644300151000},"page":"99-105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Spectrum of Genetic T-Cell Disorders from 22q11.2DS to CHARGE"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5405-0965","authenticated-orcid":false,"given":"Daniel","family":"Urschel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian P.","family":"Hernandez-Trujillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"8927_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1136\/jmg.30.10.803","volume":"30","author":"F Greenberg","year":"1993","unstructured":"Greenberg F (1993) DiGeorge syndrome an historical review of clinical and cytogenic features. J Med Genet 30:803\u2013806","journal-title":"J Med Genet"},{"key":"8927_CR2","doi-asserted-by":"publisher","unstructured":"McDonald-McGinn DM, Sullivan KE, Marino B et al (2015) 22q11.2 deletion syndrome. Nat Rev Dis Primers 1:15071. Published 2015 Nov 19. https:\/\/doi.org\/10.1038\/nrdp.2015.71","DOI":"10.1038\/nrdp.2015.71"},{"key":"8927_CR3","doi-asserted-by":"crossref","unstructured":"Bassett AS et al (2011) Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr 159:332.e331\u2013339.e331","DOI":"10.1016\/j.jpeds.2011.02.039"},{"key":"8927_CR4","doi-asserted-by":"crossref","unstructured":"McDonald-McGinn DM, Sullivan K (2011) Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome) Medicine\u00a090:1\u201318","DOI":"10.1097\/MD.0b013e3182060469"},{"key":"8927_CR5","doi-asserted-by":"crossref","unstructured":"Sellier C et al (2014) Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11.2 deletion syndrome. PLoS One 9:e103884","DOI":"10.1371\/journal.pone.0103884"},{"key":"8927_CR6","doi-asserted-by":"publisher","unstructured":"Saitta SC, Harris SE, Gaeth AP et al (2004) Aberrant interchromosomal exchanges are the predominant cause of the 22q11.2 deletion. Hum Mol Genet 13(4):417\u2013428. https:\/\/doi.org\/10.1093\/hmg\/ddh041","DOI":"10.1093\/hmg\/ddh041"},{"key":"8927_CR7","doi-asserted-by":"crossref","unstructured":"Guna A, Butcher NJ, Bassett AS (2015) Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms. J Neurodev Disord 7:18","DOI":"10.1186\/s11689-015-9113-x"},{"key":"8927_CR8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/85845","volume":"27","author":"LA Jerome","year":"2001","unstructured":"Jerome LA, Papaioannou VE (2001) DiGeorge syndrome phenotype in mice mutant for the T-box gene Tbx1. Nat Genet 27:286\u2013291","journal-title":"Nat Genet"},{"key":"8927_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ajhg.2014.12.025","volume":"96","author":"SE Racedo","year":"2015","unstructured":"Racedo SE et al (2015) Mouse and human CRKL is dosage sensitive for cardiac outflow tract formation. Am J Hum Genet 96:235\u2013244","journal-title":"Am J Hum Genet"},{"key":"8927_CR10","doi-asserted-by":"crossref","unstructured":"McDonald-McGinn DM et al (2013) Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS. J Med Genet 50:80\u201390","DOI":"10.1136\/jmedgenet-2012-101320"},{"key":"8927_CR11","unstructured":"McDonald-McGinn DM et al (2014) The perplexing prevalence of familial nested 22q11.2 deletions. ASGH.\u00a0[online].\u00a0http:\/\/www.ashg.org\/2014meeting\/abstracts\/fulltext\/f140120440.htm."},{"key":"8927_CR12","doi-asserted-by":"crossref","unstructured":"McDonald-McGinn DM et al (2005) The 22q11.2 deletion in African-American patients: an underdiagnosed population? Am J Med.Genet A 134:242\u2013246","DOI":"10.1002\/ajmg.a.30069"},{"key":"8927_CR13","doi-asserted-by":"crossref","unstructured":"Liu AP et al (2014) Under-recognition of 22q11.2 deletion in adult Chinese patients with conotruncal anomalies: implications in transitional care. Eur J Med Genet\u00a057:306\u2013311","DOI":"10.1016\/j.ejmg.2014.03.014"},{"issue":"1","key":"8927_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jaip.2019.05.050","volume":"8","author":"H Ale","year":"2020","unstructured":"Ale H, Beiro Z, Blouin W, Calderon J, Hernandez-Trujillo VP (2020) Pediatric Hispanic versus non-Hispanic patients with partial DiGeorge syndrome. J Allergy Clin Immunol Pract 8(1):383\u2013384","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8927_CR15","doi-asserted-by":"crossref","unstructured":"Bassett AS et al (2009) Premature death in adults with 22q11.2 deletion syndrome. J Med Genet 46:324\u2013330","DOI":"10.1136\/jmg.2008.063800"},{"key":"8927_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/humu.20330","volume":"27","author":"JA Vorstman","year":"2006","unstructured":"Vorstman JA et al (2006) MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q. Hum Mut 27:814\u2013821","journal-title":"Hum Mut"},{"issue":"4","key":"8927_CR17","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jaci.2004.01.766","volume":"113","author":"ML Markert","year":"2004","unstructured":"Markert ML et al (2004) Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. J Allergy Clin Immunol 113(4):734\u2013741","journal-title":"J Allergy Clin Immunol"},{"key":"8927_CR18","doi-asserted-by":"crossref","unstructured":"Patel K, Akhter J, Kobrynski L, Benjamin Gathmann MA, Davis O, Sullivan KE (2012) International DiGeorge Syndrome Immunodeficiency Consortium. Immunoglobulin deficiencies: the B-lymphocyte side of DiGeorge syndrome. J Pediatr 161(5):950\u20133","DOI":"10.1016\/j.jpeds.2012.06.018"},{"key":"8927_CR19","doi-asserted-by":"crossref","unstructured":"Repetto GM et al (2014) Case fatality rate and associated factors in patients with 22q11 microdeletion syndrome: a retrospective cohort study. BMJ Open 4:e005041","DOI":"10.1136\/bmjopen-2014-005041"},{"key":"8927_CR20","doi-asserted-by":"publisher","unstructured":"Sullivan KE, Crowley TB, Maurer K et al (2018) T-cell lymphopenia in 22q11.2 deletion syndrome: relationship to cardiac disease. J Allergy Clin Immunol Pract 6(2):690\u2013691.\u00a0https:\/\/doi.org\/10.1016\/j.jaip.2017.08.028","DOI":"10.1016\/j.jaip.2017.08.028"},{"key":"8927_CR21","doi-asserted-by":"crossref","unstructured":"Sullivan KE, Jawad AF et al (1998) Lack of correlation between impaired T cell production, immunodeficiency and other phenotypic features in chromosome 22q11.2 deletions syndrome (DiGeorge syndrome\/velocardiofacial syndrome). Clin Immunol Immunopathol\u00a084: 141\u2013146","DOI":"10.1006\/clin.1997.4463"},{"key":"8927_CR22","doi-asserted-by":"crossref","unstructured":"Sullivan KE, Burrows E, McDonald-McGinn DM (2016) Healthcare utilization in chromosome 22q11.2 deletion patients with cardiac disease and low T cell counts. Am J Med Genet A 170: 1630\u20131634","DOI":"10.1002\/ajmg.a.37648"},{"key":"8927_CR23","doi-asserted-by":"crossref","unstructured":"Dyce O et al (2002) Otolaryngologic manifestations of the 22q11.2 deletion syndrome. Arch Otolaryngol Head Neck Surg 128:1408\u20131412","DOI":"10.1001\/archotol.128.12.1408"},{"key":"8927_CR24","doi-asserted-by":"crossref","unstructured":"Weinzimer SA (2001) Endocrine aspects of the 22q11.2 deletion syndrome. Genet Med 3:19\u201322","DOI":"10.1097\/00125817-200101000-00005"},{"key":"8927_CR25","first-page":"137","volume":"36","author":"MC Digilio","year":"1999","unstructured":"Digilio MC, Marino B, Bagolan P, Giannotti A, Dallapiccola B (1999) Microdeletion 22q11 and oesophageal atresia. J Med Genet 36:137\u2013139","journal-title":"J Med Genet"},{"key":"8927_CR26","doi-asserted-by":"crossref","unstructured":"Eicher PS et al (2000) Dysphagia in children with a 22q11.2 deletion: unusual pattern found on modified barium swallow. J Pediatr\u00a0137:158\u2013164","DOI":"10.1067\/mpd.2000.105356"},{"key":"8927_CR27","doi-asserted-by":"crossref","unstructured":"Mercer-Rosa L, Pinto N, Yang W, Tanel R, Goldmuntz E (2013) 22q11.2 deletion syndrome is associated with perioperative outcome in tetralogy of Fallot. J Thorac Cardiovasc Surg 146:868\u2013873","DOI":"10.1016\/j.jtcvs.2012.12.028"},{"key":"8927_CR28","doi-asserted-by":"crossref","unstructured":"Carotti A et al (2008) Cardiac defects and results of cardiac surgery in 22q11.2 deletion syndrome. Dev Disabil Res Rev 14:35\u201342","DOI":"10.1002\/ddrr.6"},{"issue":"6","key":"8927_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/adc.2006.097493","volume":"92","author":"V Waters","year":"2007","unstructured":"Waters V, Peterson KS, LaRussa P (2007) Live viral vaccines in a DiGeorge syndrome patient. Arch Dis Child 92(6):519\u2013520. https:\/\/doi.org\/10.1136\/adc.2006.097493","journal-title":"Arch Dis Child"},{"key":"8927_CR30","doi-asserted-by":"publisher","unstructured":"Perez EE, Bokszczanin A, McDonald-McGinn D, Zackai EH, Sullivan KE (2003) Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome). Pediatrics 112(4):e325.\u00a0https:\/\/doi.org\/10.1542\/peds.112.4.e325\u00a0 (PMID: 14523220)","DOI":"10.1542\/peds.112.4.e325"},{"key":"8927_CR31","doi-asserted-by":"publisher","unstructured":"Moylett EH, Wasan AN, Noroski LM, Shearer WT (2004) Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity. Clin Immunol 112(1)106-112.\u00a0https:\/\/doi.org\/10.1016\/j.clim.2004.02.008\u00a0(PMID: 15207787)","DOI":"10.1016\/j.clim.2004.02.008"},{"issue":"4","key":"8927_CR32","doi-asserted-by":"publisher","first-page":"e946","DOI":"10.1542\/peds.2013-0831","volume":"133","author":"AM Hofstetter","year":"2014","unstructured":"Hofstetter AM, Jakob K, Klein NP, Dekker CL, Edwards KM, Halsey NA, Baxter R, Williams SE, Graham PL 3rd, LaRussa P (2014) Live vaccine use and safety in DiGeorge syndrome. Pediatrics 133(4):e946\u2013e954. https:\/\/doi.org\/10.1542\/peds.2013-0831 (Epub 2014 Mar 31 PMID: 24685951)","journal-title":"Pediatrics"},{"issue":"4","key":"8927_CR33","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jaci.2010.07.018","volume":"126","author":"N Al-Sukaiti","year":"2010","unstructured":"Al-Sukaiti N, Reid B, Lavi S, Al-Zaharani D, Atkinson A, Roifman CM, Grunebaum E (2010) Safety and efficacy of measles, mumps, and rubella vaccine in patients with DiGeorge syndrome. J Allergy Clin Immunol 126(4):868\u2013869. https:\/\/doi.org\/10.1016\/j.jaci.2010.07.018 (PMID: 20810153)","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8927_CR34","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.jaci.2017.03.020","volume":"140","author":"EG Davies","year":"2017","unstructured":"Davies EG et al (2017) Thymus transplantation for complete DiGeorge syndrome: European experience. J Allergy Clin Immunol 140(6):1660-1670.e16. https:\/\/doi.org\/10.1016\/j.jaci.2017.03.020","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8927_CR35","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3892\/etm.2017.5362","volume":"15","author":"M Zhang","year":"2018","unstructured":"Zhang M, Li FX, Liu XY et al (2018) TBX1 loss-of-function mutation contributes to congenital conotruncal defects. Exp Ther Med 15(1):447\u2013453. https:\/\/doi.org\/10.3892\/etm.2017.5362","journal-title":"Exp Ther Med"},{"issue":"1","key":"8927_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1136\/jmg.37.1.33","volume":"37","author":"P Lichtner","year":"2000","unstructured":"Lichtner P, K\u00f6nig R, Hasegawa T, Van Esch H, Meitinger T, Schuffenhauer S (2000) An HDR (hypoparathyroidism, deafness, renal dysplasia) syndrome locus maps distal to the DiGeorge syndrome region on 10p13\/14. J Med Genet 37(1):33\u201337. https:\/\/doi.org\/10.1136\/jmg.37.1.33","journal-title":"J Med Genet"},{"key":"8927_CR37","doi-asserted-by":"crossref","unstructured":"Jyonouchi S, McDonald-McGinn D, Bale S, Zachai E, Sullivan KE (2009) CHARGE (coloboma, heart defect, atresia choanae,retarded growth and development, genital hypoplasia, ear anomslies\/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features. Pediatrics 123:e871-e877","DOI":"10.1542\/peds.2008-3400"},{"issue":"8","key":"8927_CR38","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10875-015-0211-z","volume":"35","author":"VA Dalm","year":"2015","unstructured":"Dalm VA, Driessen GJ, Barendregt BH, van Hagen PM, van der Burg M (2015) The 11q Terminal deletion disorder Jacobsen syndrome is a syndromic primary immunodeficiency. J Clin Immunol 35(8):761\u2013768. https:\/\/doi.org\/10.1007\/s10875-015-0211-z","journal-title":"J Clin Immunol"},{"issue":"3","key":"8927_CR39","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ajhg.2019.07.014","volume":"105","author":"M Bosticardo","year":"2019","unstructured":"Bosticardo M, Yamazaki Y, Cowan J et al (2019) Heterozygous FOXN1 variants cause low TRECs and severe T cell lymphopenia, revealing a crucial role of FOXN1 in supporting early thymopoiesis. Am J Hum Genet 105(3):549\u2013561. https:\/\/doi.org\/10.1016\/j.ajhg.2019.07.014","journal-title":"Am J Hum Genet"},{"issue":"2","key":"8927_CR40","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1182\/blood-2010-06-292490","volume":"117","author":"ML Markert","year":"2011","unstructured":"Markert ML, Marques JG, Neven B et al (2011) First use of thymus transplantation therapy for FOXN1 deficiency (nude\/SCID): a report of 2 cases. Blood 117(2):688\u2013696. https:\/\/doi.org\/10.1182\/blood-2010-06-292490","journal-title":"Blood"},{"issue":"11","key":"8927_CR41","doi-asserted-by":"publisher","first-page":"4724","DOI":"10.1172\/JCI127565","volume":"129","author":"Q Du","year":"2019","unstructured":"Du Q, Huynh LK, Coskun F, Markert ML et al (2019) FOXN1 compound heterozygous mutations cause selective thymic hypoplasia in humans. J Clin Invest 129(11):4724\u20134738. https:\/\/doi.org\/10.1172\/JCI127565","journal-title":"J Clin Invest"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-022-08927-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-022-08927-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-022-08927-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T14:31:04Z","timestamp":1673447464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-022-08927-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["8927"],"URL":"https:\/\/doi.org\/10.1007\/s12016-022-08927-z","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"assertion":[{"value":"13 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/S","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"N\/S","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Both authors give their consent to publish this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Dr. Urschel has no conflict of interest related to the subject of this manuscript. Dr. Hernandez-Trujillo has participated in advisory boards for Takeda, CSL, and Regeneron\/Sanofi. Dr. Hernandez-Trujillo is a speaker and consultant for Takeda. Dr. Hernandez-Trujillo is a member of the Immune Deficiency Foundation Medical Advisory Committee.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}